Validea's guru fundamental report assigns STRYKER CORP (SYK), a large-cap medical equipment stock, an 87% rating under the Pim van Vliet Multi-Factor Investor model. This strategy targets low volatility stocks with strong momentum and high net payout yields. While the 87% score indicates 'some interest,' the detailed analysis reveals SYK received 'Neutral' for momentum and net payout yield, and a 'Fail' on its 'Final Rank,' suggesting a nuanced fit despite its relatively strong overall rating within the model.
According to a Validea fundamental report, Stryker Corp (SYK) scores an 87% rating based on the Pim van Vliet Multi-Factor Investor model, a level indicating 'some interest'. This model specifically targets large-cap, low-volatility stocks that also exhibit strong momentum and a high net payout yield. While SYK fulfills the model's requirements for market capitalization and low volatility, passing the standard deviation test, its profile is weakened by 'Neutral' ratings for both its 'Twelve Minus One Momentum' and 'Net Payout Yield'. Critically, the stock received a 'Fail' on the model's 'Final Rank' criterion. This presents a conflicting signal: SYK aligns with the defensive, low-risk aspect of the strategy but lacks the return-enhancing characteristics of momentum and shareholder yield that the model also seeks, culminating in a failure on the composite final ranking.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.40
Ticker Sentiment
